Ilya Levental, PhD, and Collaborators Earn $3.3 Million to Research Mechanisms by Which Immune Cells Fight Infection or Cancer - Research - Medicine in Motion News

Ilya Levental, PhD, and Collaborators Earn $3.3 Million to Research Mechanisms by Which Immune Cells Fight Infection or Cancer

Backed by a new five-year $3.3 million award from the National Institute of Allergy and Infectious Disease, Ilya Levental, PhD, a professor in the Department of Molecular Physiology and Biological Physics, and his collaborators aim to uncover the fun...

Medicine in Motion News

Committee on Women in Medicine and Science Honors Wendy Novicoff, PhD as February Woman of the Month - Medicine in Motion News

Committee on Women in Medicine and Science Honors Wendy Novicoff, PhD

Wendy Novicoff, PhD, a professor in the Department of Public Health Sciences (PHS) and program director for both the Master of Science in Clinical Research program and the PHS Certificate program, has been named the Committee on Women in Medicine and...

Medicine in Motion News

Research in Motion: Patrick Finan, PhD - Medicine in Motion News

Research in Motion: Patrick Finan, PhD

I am a clinical pain psychologist, and we approach the field of pain medicine by looking at opportunities to identify and intervene on emotional factors that influence chronic pain. —Patrick Finan, PhD, Professor, Department of Anesthesiology To wa...

Medicine in Motion News

Shrirang Gadrey, MBBS, MPH, Awarded $4 Million to Study Physiological Signatures of Labored Breathing - Research - Medicine in Motion News

Shrirang Gadrey Awarded $4 Million to Study Physiological Signatures of Labored Breathing

Shrirang Gadrey, MBBS, MPH, an associate professor in the Department of Medicine, Division of Hospital Medicine was awarded a $4 million NIH grant for a project titled “Novel physiomarkers of high-risk labored breathing for advance warning of clini...

Medicine in Motion News

Ovarian Cancer Discovery Could Turn Failed Treatment Into Lifesaver

Ovarian Cancer Discovery Could Turn Failed Treatment Into Lifesaver

Gut bacteria are to blame for the failure of immune checkpoint therapy for ovarian cancer, new UVA Health research reveals.

UVA Health Newsroom